...

BERKELEY HEIGHTS, N.J., July 7, 2015 (GLOBE NEWSWIRE) -- Authentidate Holding Corp.(Nasdaq:ADAT), a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations, announced today that Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, selected Authentidate's telehealth solution for the remote monitoring of some of the dialysis patients who have kidney failure. The roll out is expected to begin in the third quarter of 2015.

In 2012, there were more than 20 million people in the United States (10% of the population) with some level of Chronic Kidney Disease (CKD) according to the Centers for Disease Control and Prevention. RVM serves CKD patients through their network of dialysis centers, which include 35 dialysis partnerships and 26 inpatient service contracts across the U.S. While RVM patients' overall quality scores are better than national averages, RVM's goal is to continue to improve those quality scores and Authentidate's solutions will be integral to this enhancement.

Authentidate's Telehealth Solution is designed to help patients achieve their goals to get healthy and stay healthy with an easy to use mobile device that captures vital signs, symptoms, and treatment plan compliance in the home and shares the associated data in real time with the patient's care givers via the internet. 

RVM Chief Medical Officer George R. Aronoff, MD, MS, FACP, commented, "Patients with kidney failure are at high risk during the first four months of starting dialysis treatments. We are enthusiastic about using Authentidate telehealth services for health informatics, disease management and remote monitoring technologies to enhance care and case management for our most vulnerable patients. At Renal Ventures Management, we believe that home monitoring using telehealth technology provides an innovative tool for our patients and care givers to improve wellness and quality of life."

The RVM application is another excellent use case for Authentidate's proven and innovative solution for remote patient management and aligns with the company's focus on improving quality of care and reducing the cost of care. RVM remains committed to meeting the increasing demand in the market for flexible and effective remote patient management.

"Authentidate's remote patient management solutions have helped thousands of patients across the commercial and government healthcare sectors, and our recent innovations are powerful tools in patient care. We're excited about RVM's thought leadership and are proud of the support our solutions bring to the RVM team as they have a positive impact on their patients' lives," said Ian Bonnet, President and CEO of Authentidate.

Mr. Bonnet added, "The dialysis segment is a niche where our solutions can have a positive impact and an extension of our proven disease management protocols. This agreement calls for RVM to purchase both our proprietary telehealth devices and associated software subscriptions for the benefit of their patients. The agreement was reached as an outcome of the renewed focus and strategy we have at Authentidate. We are working on partnering with other industry leaders like RVM and hope to be able to announce additional contracts in the future."

About Renal Ventures Management, LLC

Renal Ventures Management, LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management provides management expertise and patient-focused care operations which center around collaboration, quality and effectiveness. Headquartered in Lakewood, Colo., the company operates 35 dialysis partnerships and 26 inpatient service contracts in six states. They also operate seven infusion centers in two states treating patients with various autoimmune disorders and a vascular access center in Lafayette, Louisiana.

For more information, visit www.renalventures.com

About Authentidate Holding Corp.

Authentidate Holding Corp. is a provider of web-based revenue cycle management applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Authentidate's products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate's telehealth solutions combine patient vital signs monitoring with a web application that streamlines patient care management. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access our web-based applications thereby utilizing previous investments in systems and technology. The company's healthcare customers and users include leading homecare companies, health systems, and physician groups. These organizations utilize the company's products and services to coordinate care for patients outside of acute care.

For more information, visit www.authentidate.com

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words "believe," "anticipate," "think," "intend," "plan," "will be," "expect," and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company's ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.

Authentidate, Inscrybe and InscrybeMD are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.

Media Contacts:

Authentidate Holding Corp.
James Carbonara, Hayden IR,
 (646) 755-7412

Brett Maas, Hayden IR,
 (646) 536-7331

Renal Ventures Management, LLC
Kim Travis, (303) 384-4160

...

(HealthDay News) -- Young adults with even slightly elevated blood pressure may be at risk of cardiac dysfunction later in life, according to a new study published in the Journal of the American College of Cardiology.

Researchers followed 2,479 men and women over the course of 25 years. They were between 18 and 30 years old when the study began. During the study period, researchers looked at the participants' health 7 times. Part of their evaluations included blood pressure readings. Towards the end of the study, the researchers also performed cardiac imaging tests.

The researchers found that participants who had slightly elevated blood pressure that was still considered within normal range when they were between 18 and 30 years old were more likely to have problems with their left ventricle once they reached middle age.

"Our findings provide further support for the importance of good risk factor control early in life," lead author João Lima, M.D., from the cardiology division at the Johns Hopkins University School of Medicine in Baltimore, said in a journal news release. "Many participants were not hypertensive at the beginning of the study; however, chronic exposure to higher blood pressure, even within what is considered the normal range, is associated with cardiac dysfunction 25 years later."

Sources

1. Kishi, S, et al. J Am Coll Cardiol.2015;65(25):2679-2687. doi:10.1016/j.jacc.2015.04.042.
2. Thomas H. Marwick and Alison J. Venn. Am Coll Cardiol., 2015;65(25):2688-2690; doi: 10.1016/j.jacc.2015.04.040.

...

...